The Asia Pacific Cough Syrup Market would witness market growth of 6.5% CAGR during the forecast period (2020-2026). The OTC cough and cold medications, which are commonly available in stores, consist of a single or combined mixture of a cough suppressant, a decongestant, expectorant, antihistamine, and antipyretic.
There are many parents who use cough and cold medications to provide a temporary relief from the symptoms of upper respiratory infections causing in children, these symptoms may vary from a runny nose, cough, congestion, and fever. Though, a person who has a dry & hacking cough can take dextromethorphan only on prescription. Mostly, the cough syrups & medicines are not utilized to suppress cough, in cases where a person has cough with mucus. An effective cough syrup can be used to clear secretions & mucus from the airways.
This medication is consumed to get relief from a cough caused by bronchitis, a common cold, and various other breathing issues. Guaifenesin is among the group of drugs called expectorants. It helps in breaking and narrowing down mucus in the airways, clearing congestion, and improving breathing rate. Dextromethorphan comes under cough suppressants class of medicines. It helps in reducing the urge to cough. Before consuming these medications, a person should consult a doctor or for self-consumption, a person should be aware of the effect it might cause on them and also read the intake information carefully.
All the cough & cold products are not necessarily safe or effective for children below 6 years of age. Thus, it is necessary to avoid using these products to cure cough or cold symptoms in children below the age of 6 years and it is prescribed to consult a doctor first, before giving any medication to children. These medications could have some side effects that can vary from person to person or depends on the intake dosage of cough syrups. The cough & cold products do not treat the common cold properly and can even cause various serious side effects. It is important to precisely follow the dosage instruction in order to reduce the risk of side effects.
The China market dominated the Asia Pacific Hospital Pharmacy Market by Country in 2019, growing at a CAGR of 3.1 % during the forecast period. The India market is anticipated to witness a CAGR of 6.3% during (2020 - 2026). Additionally, The Japan market is showcasing a CAGR of 6.3% during (2020 - 2026).
The Cough Suppressants market dominated the Malaysia Cough Syrup Market by Product in 2019, thereby, achieving a market value of $102.7 million by 2026. The Combination Medications market is experiencing a CAGR of 6.4% during (2020 - 2026). Additionally, The Expectorants market is expected to witness highest CAGR of 7.6% during (2020 - 2026).
Based on Product, the market is segmented into Cough Suppressants, Combination Medications and Expectorants. Based on Age Group, the market is segmented into Adult and Pediatric. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Cough Syrup Market in Asia Pacific is expected to register a CAGR of 6.5% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Merck Group, Johnson and Johnson, GlaxoSmithKline PLC (GSK), The Procter and Gamble Company, Reckitt Benckiser Group PLC, Abbott Laboratories, Sanofi S.A., and Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC).
By Product
By Age Group
By Distribution Channel
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 